FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

Endocannabinoids

Loren Parsons, Matthew Hill
    Product form
      FORMAT: Hardback

      R 6,179.00 Price and availability exclusive to website

      YOU COULD EARN 6,179 FUTURE RETAIL DISCOUNTS.
      ESTIMATED DELIVERY: Approx. 20 - 30 Business Days
      BUY NOW PAY LATER
      From R 1,029.83 per month!
      3x monthly payments of R 2,059.66 with
      4x fortnightly payments of R 1,544.75 with
      Endocannabinoids, the latest volume in the International Review of Neurobiology series is a comprehensive overview of the state-of-the-art research into the neurobiology of migraines. It reviews the current knowledge and understanding in the field, and provides a starting point for researchers and practitioners entering the field.
      Format: CONTRIBUTORS: Loren Parsons, Matthew Hill EAN: 9780128012789 COUNTRY: United States PAGES: WEIGHT: 700 g HEIGHT: 229 cm
      PUBLISHED BY: Elsevier Science Publishing Co Inc DATE PUBLISHED: 2015-11-27 CITY: GENRE: MEDICAL / Neurology, SCIENCE / Life Sciences / Neuroscience WIDTH: 152 cm SPINE:

      Book Themes:

      Neurosciences

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Matthew Hill is an Assistant Professor in the Departments of Cell Biology and Anatomy and Psychiatry at the Hotchkiss Brain Institute at the University of Calgary (Canada). He was trained in Behavioral Neuroscience and Psychoneuroendocrinology at the University of British Columbia and did postdoctoral training in the laboratory of Dr. Bruce McEwen at the Rockefeller University. Dr. Hill’s research has helped to reveal the critical role, and neural circuits through which, endocannabinoid signaling regulates acute responsiveness and adaptation of the stress response, both at the neuroendocrine and behavioral level. Further, his research has demonstrated how chronic stress can compromise endocannabinoid function, identifying this system as target for both the pathophysiology and treatment of stress-related mood and anxiety disorders. This research program is funded by CIHR, NSERC and Brain Canada. Dr. Hill has done consulting with Health Canada regarding their information document for health care professionals providing information on cannabis, as well as in industry where he has consulted with both Pfizer and Johnson & Johnson regarding their endocannabinoid research programs and potential applications to stress-related psychiatric illnesses.
      Endocannabinoids, the latest volume in the International Review of Neurobiology series is a comprehensive overview of the state-of-the-art research into the neurobiology of migraines. It reviews the current knowledge and understanding in the field, and provides a starting point for researchers and practitioners entering the field.
      Format: CONTRIBUTORS: Loren Parsons, Matthew Hill EAN: 9780128012789 COUNTRY: United States PAGES: WEIGHT: 700 g HEIGHT: 229 cm
      PUBLISHED BY: Elsevier Science Publishing Co Inc DATE PUBLISHED: 2015-11-27 CITY: GENRE: MEDICAL / Neurology, SCIENCE / Life Sciences / Neuroscience WIDTH: 152 cm SPINE:

      Book Themes:

      Neurosciences

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Matthew Hill is an Assistant Professor in the Departments of Cell Biology and Anatomy and Psychiatry at the Hotchkiss Brain Institute at the University of Calgary (Canada). He was trained in Behavioral Neuroscience and Psychoneuroendocrinology at the University of British Columbia and did postdoctoral training in the laboratory of Dr. Bruce McEwen at the Rockefeller University. Dr. Hill’s research has helped to reveal the critical role, and neural circuits through which, endocannabinoid signaling regulates acute responsiveness and adaptation of the stress response, both at the neuroendocrine and behavioral level. Further, his research has demonstrated how chronic stress can compromise endocannabinoid function, identifying this system as target for both the pathophysiology and treatment of stress-related mood and anxiety disorders. This research program is funded by CIHR, NSERC and Brain Canada. Dr. Hill has done consulting with Health Canada regarding their information document for health care professionals providing information on cannabis, as well as in industry where he has consulted with both Pfizer and Johnson & Johnson regarding their endocannabinoid research programs and potential applications to stress-related psychiatric illnesses.

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account